# Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study

> **NCT02899741** · PHASE2 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Omega-3

## Key facts

- **NCT ID:** NCT02899741
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2018-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02899741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02899741, "Efficacy of Omega-3 as Adjunctive Therapy for Medically Intractable Epilepsy: A Prospective Open-label Pilot Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02899741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*